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Abstract 
Aim This study aims to define patterns of Hirschsprung disease (HD) management. 
Methods An online questionnaire was sent to all European Paediatric Surgeons’ Association 
(EUPSA) members. 
Results A total of 294 members (61 countries) answered (response rate: 61%). Diagnosis: All 
respondents perform rectal biopsies (61% rectal suction [RSBs], 39% open full-thickness), 96% 
contrast enema, and 31% anorectal manometry. At RSB, 17% take the most distal biopsy 1 cm 
above the dentate line, 34% take 2 cm, 30% take 3 cm, and 19% take > 3 cm. Rectal biopsy 
staining’s are hematoxylin/eosin (77%), acetylcholinesterase (74%), calretinin (31%), S100 (2%), 
nicotinamide adenine dinucleotide- tetrazolium reductase (2%), succinate dehydrogenase (1%), 
and neuron-specific enolase (1%). A total of 85% respondents recognize entities including 
hypoganglionosis (69%), intestinal neuronal dysplasia (55%), and ultrashort segment HD (50%). 
Surgery: pull through (PT) is performed at diagnosis by 33% or delayed by 67% (4 months or > 5 
kg). Awaiting definitive surgery, 77% perform rectal irrigations, 22% rectal dilatation/ 
stimulations, and 33% perform a stoma. The preferred type of PT is the Soave approach (65%), 
performed with transanal technique by 70% respondents. If symptoms persist after PT, most 
opt for conservative approach (enemas/laxatives = 76%; botulinum toxin = 27%), 30% would 
redo the PT. Total colonic aganglionosis: PT is performed in neonates (4%), at 1 to 6 months 
(29%), 6 to 12 months (37%) or older (30%). If required, a stoma is sited in the ileum (31%), 
according to intraoperative biopsies (54%), macroscopic impression (13%), and radiology (2%). 
Duhamel PT is performed by 52%, Soave by 31%, and Swenson by 17%. Overall, 31% would 
perform a J-pouch. 
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Conclusions Most aspects of HD management lack consensus with wide variations in obtaining 
a diagnosis. Transanal Soave PT is the most common technique in standard segment HD. 
Guidelines should be developed to avoid such variability in management and to facilitate 
research studies. 
 
Introduction 
Hirschsprung disease (HD), also known as congenital mega-colon, is a disorder of the enteric 
nervous system character¬ized by the absence of ganglion cells in the distal colon resulting in 
functional obstruction. The first description of this condition dates back to 1886, when Harald 
Hirsch-sprung, a Danish pediatrician, presented the first portrayal of congenital megacolon at 
the Society of Pediatrics in Berlin.1 Since then an abundant literature has grown around the 
subject, and given the many controversial aspects of HD management, several surveys of 
practice were reported by various groups. 
The Surgical Section of the American Academy of Pediat¬rics performed a survey of its 
members between 1975 and 1976 to accumulate their combined experience on HD.2 This was 
the first survey of practice reported in the literature: 33 surgeons or groups of surgeons 
returned completed forms on 1,196 patients and 181 pediatric surgeons returned individ¬ual 
preference sheets. Almost 30 years later, the American Pediatric Surgical Association (APSA) 
sent a 12-question survey to their members investigating the contemporary practice patterns in 
the surgical management of HD.3 The main change noticed between the two American surveys 
were about surgery that had shifted from a multistage approach using the Swenson or Duhamel 
techniques,2 to a one-stage minimally invasive approach using either the laparoscopic or 
transanal approaches.3 In the United King¬dom, two surveys of practice were conducted in 
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1998 and in 2010, respectively.4,5 The first survey highlighted wide var¬iations in preferred 
management strategies that led to rec-ommendations for regional subspecialization with 
dedicated HD surgeons performing definitive surgery.4 Similar to the North American 
experience, several changes in management strategy were also noticed between the two 
United Kingdom surveys with a similar trend toward the use of laparoscopy but not of transanal 
pull-through (PT).5 In Japan, three surveys were performed between 1978 and 2002.6–8 The 
latest survey reflected the changes in practice following the introduction of both laparoscopic 
surgery and transanal endorectal PT and summarized the analysis of 3,852 HD patients over 30 
years. 
The above-mentioned surveys, as well as others published in the literature, were conducted to 
investigate the practice patterns of a specific condition among a group of surgeons and to 
monitor the changes in practice that occurred over time. The aim of the present study was to 
analyze and report for the first time the patterns of HD management among the members of 
the European     Pediatric Surgeons’ Association.  
 
 
Methods 
Following approval of the European Paediatric Surgeons’ Association (EUPSA) Executive Board 
and the EUPSA Network Office, 507 members were contacted via email and asked to fill out a 
questionnaire on the management of HD using SurveyMonkey (SurveyMonkey, Palo Alto, 
California) , an   online survey platform. Response anonymity was guaranteed by the fact that 
survey creator and analyzer worked independently. The questionnaire focused on various 
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aspects of HD, such as diagnosis and surgery, and of specific patients, such as those with 
trisomy 21 and total colonic aganglionosis. A total of 25 EUPSA members opted out either 
because retired or because practicing only pediatric urology or because they do not manage HD 
patients. Of the remaining 482 members, 294 (61%) completed the questionnaire. 
Respondents were invited to fill in their position (Head of Department/Permanent Staff or 
Consultant/Trainee) and country of practice. Of the 294 respondents, 3 delegates did not 
disclose their degree, whereas 86 were head of the department (29%), 171 consultants (59%), 
and 34 trainees (12%). On 287 questionnaires, respondents reported their country of origin: 
226 (79%) were from 33 European countries and 61 (21%) from 28 non-European countries. 
 
 
Results 
Centre: Overall, 129 (45%) respondents work in centres that treat less than 10 cases of HD a 
year, 122 (42%) reported working in a centre that treats 10 to 20 HD cases a year, and 38 (13%) 
in a centre that treats more than 20 HD cases a year. 
Diagnosis: In the workup of patients with suspected HD, all respondents (100%) perform rectal 
biopsies, 96% request a contrast enema, and 31% do anorectal manometry. Rectal biopsies are 
ob¬tained using the suction technique by 61% respondents and via open full-thickness by the 
other 39% respondents; the number of specimens that are routinely taken is 3 by 55 
respondents, 2 by 28%, more than 3 by 13%, and 1 by 4% (►Fig. 1A). A total of 34% of surgeons 
take the most distal biopsy at 2 cm from the dentate line, 30% at 3 cm, 19% at more than 3 cm, 
and 17% at 1 cm (►Fig. 1B). The most used histological and immunohistochemical methods 
used for HD diagnosis are hematoxylin/eosin (77%), acetylcholinester¬ase (74%), and calretinin 
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staining (31%); other markers are less commonly used: S100 (2%), nicotinamide adenine 
dinu¬cleotide-tetrazolium reductase (2%), succinate dehydroge¬nase (1%), neuron-specific 
enolase (1%), and lactate dehydrogenase (1%) (►Fig. 1C). To receive biopsy reports it takes less 
than 24 hours for 9% of surgeons, 24 to 48 hours for 30%, 3 to 5 days for 35%, and more than 5 
days for 29% (►Fig. 1D). The majority of surgeons (85%) recognize the existence of at least one 
controversial entity including hypo¬ganglionosis (69%), intestinal neuronal dysplasia (55%), and 
ultrashort segment HD (50%) Surgery: In a neonate with confirmed HD, the next step in 
manage-ment for the majority of respondents (67%) is to perform a PT immediately. The other 
33% of respondents instead delay the PT for a median of 3 months (interquartile range: 2–5) or 
when the infant is more than 5 kg. While waiting for surgery, the bowel is maintained 
decompressed with rectal irrigations by 77% respondents, with rectal dilatation/stimulations by 
22%, whereas 33% perform a stoma. If a stoma is created in a patient with typical rectosigmoid 
HD, 34% perform a leveling stoma, 30% site it in the sigmoid colon, 26% in the right transverse 
colon, and 10% in the ileum. 
In the case of standard length aganglionic segment, the preferred type of PT is the Soave 
approach (65%, ►Fig. 2), which is performed with the transanal technique by 70% 
respondents, with laparoscopy by 20%, and by the open technique by 10%. The Swenson PT is 
the approach selected by 19% respondents, is performed with the transanal tech¬nique by 
58%, laparoscopic by 35%, and as an open technique by 7%. The Duhamel PT is performed by 
16% respondents, and is performed with the open technique by 53%, with laparoscopy by 25%, 
and as transanal by 22%. 
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The PT is planned to happen in the neonatal period by 20% respondents, between 1 and 6 
months of age by 62%, between 6 months and 1 year of age by 15%, and older than a year by 
3%.  
If symptoms persist after a “successful” PT, the majority of respondents opt for a conservative 
approach with enemas and laxatives (76%) and/or botulinum toxin injection (27%), whereas 
30% would redo the PT. Most surgeons (93%) do not change their surgical approach in patients 
with trisomy 21. The surgeons that modify their approach in the case of a patient with trisomy 
21 mostly delay the PT, create a colostomy from the beginning, and leave it for a longer period 
of time. Total colonic aganglionosis (TCA): In patients with an established diagnosis of total 
colonic aganglionosis (TCA), only 4% respondents perform the PT during the neonatal period, 
29% between 1 and 6 months of age, 37% between 6 months and 1 year of age, and 30% when 
the patient is older than a year of age. If a stoma is required, it is sited always in the ileum by 
31% respondents or according to the intraoperative biopsies by 54% or according to the 
macroscopic impression at surgery by 13%, or based on the radiological findings by 2%. The 
preferred PT in patients with TCA is the Duhamel procedure (52%), followed by Soave (31%) 
and Swenson (17%). Overall, 31% responders would perform a J-pouch in a patient with TCA.  
 
Discussion 
The results of this first survey of practice among members of the EUPSA show that most aspects 
of HD management lack consensus. The quality of data collected with this question¬naire 
derives from the seniority of the respondents (88% senior surgeons) and the internationality of 
their 61 centers (33 European and 28 non-European). Moreover, the majority of respondents 
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(55%) practice in centers that treat more than 10 HD cases a year. The response rate obtained 
with the online platform was satisfactory (61%) and higher than in other surveys on the same 
subject.2,3,5 The advantages of this method are that it reduces time and costs for data input, 
eliminates interviewer-related bias (more privacy for the respondent), minimizes errors during 
data transcription and controls answer validity.9 On the other hand, we ac¬knowledge that the 
results of this like any other surveys are based on respondent opinion rather than an on 
objective data. 
One of the most striking outcomes of this survey, not investigated by previous ones, is the 
degree of variability in obtaining HD diagnosis. Although all respondents rely on a histology-
based diagnosis and perform rectal biopsies as recommended,10 there is inconsistency in the 
way biopsies are obtained, processed, and interpreted. Almost two-thirds of respondents use 
the rectal suction technique, whereas more than a third opt for an open full-thickness biopsy. 
The difference is not just technical in specimen collection but has an implication in the 
requirement of sedation/anesthesia for the open approach. There is also a high degree of 
variability in the number of specimens collected and especially the location where the biopsy is 
taken. It is known that in the distal 1to 2 cm of the distal rectum the normal sparse nature of 
submucosal ganglion cells creates a challenge for the pathologist.11 These variations in practice 
show inconsisten¬cy and could have an effect on the different treatment modalities. The 
inconsistency in obtaining the specimens is also reflected on the pathology front, where there is 
a variability of markers used, with some being employed only in a minority of centers. Since the 
discovery that loss of calretinin immunostaining is a marker of ganglion cell absence in the 
aganglionic colon of HD patients,12 in many laboratories it has replaced acetylcholinesterase 
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staining as it can be studied on formalin-fixed, paraffin-embedded sam¬ples.13 Some authors 
have even reported that calretinin immunostaining alone may be sufficient to exclude HD,14 
although there are some scenarios where intact calretinin immunoreactive mucosal innervation 
is found in suction biopsies of HD patients13. According to our survey, calretinin immunostaining 
is not very popular as it is requested by only a third of the respondents.  
In analyzing the results of the survey, we speculated that the volume of patients treated by a 
center could have an impact on the consistency of biopsy techniques, staining markers, and 
time to reach a diagnosis. However, we did not find any relationship between center volume 
and any of the parameters mentioned. For instance, among centers that manage more than 20 
new cases of HD a year, 16% reach a definitive diagnosis within 24 hours, 24% between 24 and 
48 hours, 33% between 3 and 5 days, and 27% in more than 5 days. 
The degree of variability in obtaining and processing the rectal specimens might also have an 
impact on the different experience that certain centers have with intestinal dysgan¬glionoses, a 
heterogeneous group of anomalies of the enteric nervous system such as hypoganglionosis and 
intestinal neuronal dysplasia.15 Some surgeons have maintained a critical position regarding 
these controversial conditions as they consider these anomalies as secondary-acquired 
phe¬nomena, sometimes associated with other diseases such as bowel atresia, HD, or simple 
constipation. 
Contrast enema in patients with suspected HD is still very popular (96% respondents), although 
its utility either for HD diagnosis or for evaluation of the aganglionic segment length has been 
challenged.16,17 In a United Kingdom survey of practice only 38% surgeons combine biopsies 
with a contrast enema.5 The Australian Pediatric Surveillance Unit recom¬mend that a contrast 
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study should not be the final test to rule out HD, based on a study where only 56/126 (44%) 
patients had preoperative contrast enema which was positive in 38, giving an accuracy of 
68%.18 On the other hand, preoperative anorectal manometry is requested by only one-third 
of the respondents, maybe reflecting concerns regarding its accuracy in this age group. In the 
United Kingdom survey of practice, no surgeon re-ported the use of anorectal manometry in 
patients with suspected HD,5 whereas in a nationwide survey of 3,852 patients with HD 
managed over 30 years in Japan two-thirds of patients underwent manometry studies. The 
surgical management of HD remains one of the most controversial and diversified of all 
pediatric surgical condi¬tions. Our survey shows that in a neonate with confirmed HD two-
thirds of respondents delay the PT for a period of time, and of these 27% create a stoma. This 
shows that a one-stage repair is performed by 71% of respondents, that is not too different 
from the proportion reported in the APSA survey (86%).3 The majority of respondents who 
delay the PT plan the surgery when the infant is 3 months of age or more than 5 kg. Various 
surgical techniques have been described and em¬ployed over decades for the treatment of HD, 
but all stem from the approaches described by Orvar Swenson in 1948,19 Bernard Duhamel in 
1956,20 or Franco Soave in 1963.21 The most popular surgical approach for the respondents of 
our survey is the transanal Soave PT, followed by the transanal Swenson. This is in line with the 
APSA survey, where the coloanal anastomosis was used by almost all responding surgeons, with 
only 5.4% preserving the aganglionic rectum with the Duhamel technique.3 Also in our survey, 
the Duha¬mel is used by a smaller proportion of surgeons (16%), whereas in the United 
Kingdom it is much more commonly used (38%).5 Both the Japanese and the Australian surveys 
reported also that the Soave procedure is the commonest operation for definitive surgery.8 
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timing of the PT varies, but the majority of surgeons perform it between 1 and 6 months of age. 
This parallels the timing of the PT reported in other surveys.5,18 
The management of patients with TCA is also variable. In the present survey, the majority of 
respondents (52%) employ the Duhamel procedure for definitive surgery. This is in line with 
other surveys that report either the Duhamel or its modification such as the Lester–Martin.5,7 
Some authors have proposed the J-pouch or S-pouch ileoanal anastomosis for patients with 
TCA after failed PT procedure.22,23 This ap-proach is chosen by one-third of the respondents of 
our survey. 
We acknowledge the difficulty of interpreting some answers in this survey. As reported 
before,9 in some coun-tries, surgical units are organized in a hierarchical model, whereby the 
chief of the unit holds most of the manage-ment decisions, whereas, in other countries, units 
are run by a group of consultants/attending surgeons, each of them representing an 
independent group with autonomy regard-ing clinical decision-making. Some of the 
questionnaires analyzed in the present survey may come from the same center. Therefore, if 
more than one surgeon from the same center opt for the same PT technique, it could be due to 
an independent choice or to a center-specific management choice. This is impossible to 
extrapolate given the anonym-ity of the response analysis. 
 
In conclusion, the results of the present study highlight variation in the diagnosis and treatment 
of HD across the centers. This is reflected by the variability in obtaining rectal biopsies, the type 
of surgery, and the overall management of HD patients. The most common surgical technique 
used for PT is the transanal Soave for patients with standard segment HD. Opinions widely vary 
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about the management of patients with TCA. Guidelines should be developed to avoid such 
degree of variability in management and to facilitate research studies.  
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Figure legends 
 
Fig. 1 Differences regarding rectal biopsies for the diagnosis of Hirschsprung disease: (A) 
Number of specimens routinely taken; (B) location of the most distal biopsy from the dentate 
line; (C) most used histological and immunohistochemical methods; (D) time to pathology 
report. 
Fig. 2 Distribution of responses on the preferred definitive operation: (A) Type of pull-
through;(B)approach used for the pull-through. 
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